Merck granted its first CRISPR patent in Australia – Life Sciences Intellectual Property Review (subscription)
Life Sciences Intellectual Property Review (subscription) |
Merck granted its first CRISPR patent in Australia
Life Sciences Intellectual Property Review (subscription) On Wednesday, June 14, Merck issued a press release explaining that the office had granted it patent rights over the use of CRISPR in a genomic integration method for eukaryotic cells. The patent covers chromosomal integration (or cutting of the … |
